Paul Aisen, M.D., director of the NIA's clinical research network, discusses progress in drug development, the benefits of participating in a clinical trial, and our current knowledge about lifestyle factors and Alzheimer's. (Note: The DHA study mentioned by Dr. Aisen has reported results showing no benefit in those with Alzheimer's and a possible small benefit in those with no memory impairment.)
This video is part of the "THE ALZHEIMER'S PROJECT," a presentation of HBO Documentary Films and the National Institute on Aging at the National Institutes of Health in association with the Alzheimer's Association, The Fidelity® Charitable Gift Fund and Geoffrey Beene Gives Back® Alzheimer's Initiative.
Sign up for our weekly e-newsletter
Stay up-to-date on the latest advances in Alzheimer's treatments, care and research. Subscribe now